{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:03:12Z","timestamp":1781978592844,"version":"3.54.5"},"update-to":[{"DOI":"10.12688\/f1000research.121712.1","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000}}],"reference-count":26,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004179","name":"Ningxia Medical University","doi-asserted-by":"publisher","award":["2019BEG03069"],"award-info":[{"award-number":["2019BEG03069"]}],"id":[{"id":"10.13039\/501100004179","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>\n                    <ns4:bold>Background:<\/ns4:bold>\n                    Diabetic foot ulcers (DFUs) are a life-threatening ailment caused by diabetes. Several growth factors, as well as their various combinations, have shown promising effect in aiding diabetic foot ulcer. However, contradictory or paradoxical results are often available, and debates about this issue are ongoing. Therefore, a comprehensive meta-analysis was performed to compare the efficacy and safety of epidermal growth factor (EGF) and placebo in healing diabetic foot ulcers.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Methods:<\/ns4:bold>\n                    The database search included relevant English literature from Cochrane Library, PubMed, Google Scholar, Elsevier, and EMBASE that was published between 2009 and 2021. Inclusion criteria included type 1 and 2 diabetic patients with foot wounds focusing on complete healing rate. Exclusion criteria included combined therapy, non-human studies, reviews, and protocols. To assess the quality of each study, biases regarding random sequence generation, allocation concealment, participant and personnel blinding, outcome assessment blinding and incomplete outcome data were thoroughly identified.\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Results:<\/ns4:bold>\n                    Eight randomized control trials comprising 620 patients (337 in EGF group, 283 in placebo group), were included in this meta-analysis. EGF achieved a significantly higher complete healing rate than placebo after four weeks of treatment, with relative risk (RR): 3.04 (0.50, 18.44) and heterogeneity (Chi\n                    <ns4:sup>2<\/ns4:sup>\n                    = 6.46, df = 2 (P = 0.04) I\n                    <ns4:sup>2<\/ns4:sup>\n                    = 69 %). Notably, the healing frequency in the placebo group was 17%, whereas the healing frequency in the epidermal growth factor group was 34%. Likewise, after eight weeks of treatment, the relative risk and heterogeneity were RR: 2.59 (1.42, 4.72) and (Chi\n                    <ns4:sup>2<\/ns4:sup>\n                    =7.92, df= 4 (p= 0.09): I\n                    <ns4:sup>2<\/ns4:sup>\n                    = 49%), respectively. Moreover, the risk ratio at 12 weeks was RR: 1.01 (0.42, 2.46), and heterogeneity was (Chi\n                    <ns4:sup>2<\/ns4:sup>\n                    =8.55, df= 2 (p= 0.01): I\n                    <ns4:sup>2<\/ns4:sup>\n                    = 77%).\n                  <\/ns4:p>\n                  <ns4:p>\n                    <ns4:bold>Conclusions:<\/ns4:bold>\n                    Our findings indicate that EGF significantly promotes wound healing, and could be recommended as an effective and safe treatment for DFUs.\n                  <\/ns4:p>","DOI":"10.12688\/f1000research.121712.2","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T12:05:12Z","timestamp":1678449912000},"page":"773","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Epidermal growth factor outperforms placebo in the treatment of diabetic foot ulcer: a meta-analysis"],"prefix":"10.12688","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0555-1595","authenticated-orcid":false,"given":"Fazal","family":"Rahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jawad Ali","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3276-3005","authenticated-orcid":false,"given":"Zafar Ullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0283-9419","authenticated-orcid":false,"given":"Shah","family":"Nawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1-36","DOI":"10.1155\/2020\/1356893","article-title":"Antioxidant Effects and mechanisms of medicinal plants and their bioactive compounds for the prevention and treatment of type 2 diabetes: An updated review.","volume":"2020","author":"J Unuofin","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition.","volume":"157","author":"P Saeedi","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"21-33","DOI":"10.1080\/17446651.2017.1275960","article-title":"Understanding the impact of hypoglycemia on the cardiovascular system.","volume":"12","author":"I Davis","year":"2017","journal-title":"Expert. Rev. Endocrinol. Metab."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"211-218","DOI":"10.1016\/j.jegh.2017.10.001","article-title":"Incidence and prevalence rates of diabetes mellitus in Saudi Arabia: an overview.","volume":"7","author":"A Alotaibi","year":"2017","journal-title":"J. Epidemiol. Glob. Health."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"827-830","DOI":"10.2337\/diacare.19.8.827","article-title":"Parental history of diabetes in a population-based study.","volume":"19","author":"B Klein","year":"1996","journal-title":"Diabetes Care."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2027-2033","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study.","volume":"373","author":"C Patterson","year":"2009","journal-title":"Lancet."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1001\/jama.2018.18323","article-title":"Diabetic foot ulcers.","volume":"321","author":"D Grennan","year":"2019","journal-title":"JAMA."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2367-2375","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence.","volume":"376","author":"D Armstrong","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1493-1498","DOI":"10.1111\/dme.13054","article-title":"Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom.","volume":"33","author":"J Walsh","year":"2016","journal-title":"Diabet. Med."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"106-116","DOI":"10.1080\/07853890.2016.1231932","article-title":"Global epidemiology of diabetic foot ulceration: A review and meta-analysis.","volume":"49","author":"P Zhang","year":"2017","journal-title":"Ann. Med."},{"key":"ref14","article-title":"IDF diabetes atlas.","year":"2012"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"278-284","DOI":"10.1038\/bmt.2010.110","article-title":"Bone marrow mononuclear cells versus G-CSF-mobilized peripheral blood mononuclear cells for treatment of lower limb ASO: pooled analysis for long-term prognosis.","volume":"46","author":"R Onodera","year":"2011","journal-title":"Bone Marrow Transplant."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40824-016-0056-4","article-title":"Development of Stabilized Growth Factor-Loaded Hyaluronatee Collagen Dressing (HCD) matrix for impaired wound healing.","volume":"20","author":"S Choi","year":"2016","journal-title":"Biomater Res."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e1873","DOI":"10.1097\/MD.0000000000001873","article-title":"Promoting diabetic wound therapy using biodegradable rhPDGF-Loaded nanofibrous membranes: CONSORT-compliant article.","volume":"94","author":"C Lee","year":"2015","journal-title":"Medicine."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"394-398","DOI":"10.1097\/01.sap.0000198731.12407.0c","article-title":"Recombinant human epidermal growth factor (EGF) to enhance healing for diabetic foot ulcers.","volume":"56","author":"J Hong","year":"2006","journal-title":"Ann. Plast. Surg."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"190-196","DOI":"10.1016\/j.avsg.2018.05.036","article-title":"Peripheral Blood Mononuclear Cells Therapy for Treatment of Lower Limb Ischemia in Diabetic Patients: a Single-Center Experience.","volume":"53","author":"F Persiani","year":"2018","journal-title":"Ann. Vasc. Surg."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"120-125","DOI":"10.1177\/1534734616645444","article-title":"Efficacy of topical recombinant human epidermal growth factor for treatment of diabetic foot ulcer: a systematic review and meta-analysis.","volume":"15","author":"S Yang","year":"2016","journal-title":"Int. J. Low Extrem. Wounds."},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3390\/ijerph16142584","article-title":"Epidermal growth factor is effective in the treatment of diabetic foot ulcers: meta-analysis and systematic review.","volume":"16","author":"B Thien Quoc","year":"2019","journal-title":"Int. J. Environ. Res. Public Health."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"442-451","DOI":"10.1016\/j.avsg.2019.05.041","article-title":"Topical recombinant human epidermal growth factor for diabetic foot ulcers: a met analysis of randomized controlled clinical trials.","volume":"62","author":"Q Yang","year":"2020","journal-title":"Ann. Vasc. Surg."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"158-164","DOI":"10.1177\/1534734619892791","article-title":"Efficacy of Recombinant Human Epidermal Growth Factor (Regen-D 150) in Healing Diabetic Foot Ulcers: A Hospital-Based Randomized Controlled Trial.","volume":"19","author":"V Viswanathan","year":"2019","journal-title":"Int. J. Low Extrem. Wounds."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"405-411","DOI":"10.1016\/j.diabres.2007.06.004","article-title":"Recombinant human epidermal growth factor (REGEN-D 150): effect on healing of diabetic foot ulcers.","volume":"78","author":"V Mohan","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2249-9571","DOI":"10.17354\/ijss\/2015\/276","article-title":"The Role of Epidermal Growth Factor Cream in Healing of Diabetic Foot Ulcer - Comparative Analytical Study in South India.","volume":"8","author":"D Thambi","year":"2019","journal-title":"Int. J. Health Sci. Res."},{"key":"ref27","first-page":"82-88","article-title":"Efficacy of topical recombinant epidermal growth factor as compared to Povidone Iodine on chronic diabetic foot ulcers.","volume":"3","author":"A Kumar","year":"2020","journal-title":"Int. J. Health Clin. Res."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"442-451","DOI":"10.1016\/j.avsg.2019.05.041","article-title":"Topical Recombinant Human Epidermal Growth Factor for Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Clinical Trials.","volume":"62","author":"Y Qi","year":"2020"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.19928645.v1","article-title":"PRISMA_2020_checklist.docx. figshare.","author":"R Fazal","year":"2022"}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/11-773\/v2\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/11-773\/v2\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/11-773\/v2\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:15:13Z","timestamp":1697710513000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/11-773\/v2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":26,"URL":"https:\/\/doi.org\/10.12688\/f1000research.121712.2","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.145397.r202888","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.145397.r211405","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.145397.r202888","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.145397.r211405","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/11-773\/v2#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.145397.r202888, Chin Chai Yee, School of Pharmacy, Faculty of Health and Medical Science, Taylor's University, Subang Jaya, Selangor, 18 Sep 2023, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/11-773\/v2#referee-response-202888","order":0,"name":"referee-response-202888","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.145397.r211405, Poonam Kushwaha, Faculty of Pharmacy, Integral University, Lucknow, Uttar Pradesh, 19 Oct 2023, version 2, indexed","URL":"https:\/\/f1000research.com\/articles\/11-773\/v2#referee-response-211405","order":1,"name":"referee-response-211405","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"This work was supported by key Research & development projects of Ningxia Hui Autonomous region at Ningxia medical university 2019, under the Grant number: 2019BEG03069. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}